Literature DB >> 33367371

Targeted nanoscale therapeutics for myocardial infarction.

Holly L Sullivan1, Nathan C Gianneschi, Karen L Christman.   

Abstract

Nanoscale therapeutics have promise for the administration of therapeutic small molecules and biologics to the heart following myocardial infarction. Directed delivery to the infarcted region of the heart using minimally invasive routes is critical to this promise. In this review, we will discuss the advances and design considerations for two nanoscale therapeutics engineered to target the infarcted heart, nanoparticles and adeno-associated viruses.

Entities:  

Mesh：

Year:  2020        PMID： 33367371      PMCID： PMC7932032          DOI： 10.1039/d0bm01677b

Source DB:  PubMed          Journal:  Biomater Sci        ISSN： 2047-4830            Impact factor:   6.843


  87 in total

1.  PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization.

Authors:  Gary K Lee; Narendra Maheshri; Brian Kaspar; David V Schaffer
Journal:  Biotechnol Bioeng       Date:  2005-10-05       Impact factor: 4.530

2.  Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction.

Authors:  Q Li; R Bolli; Y Qiu; X L Tang; Y Guo; B A French
Journal:  Circulation       Date:  2001-04-10       Impact factor: 29.690

3.  Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

Authors:  V Menon; J G Webb; L D Hillis; L A Sleeper; R Abboud; V Dzavik; J N Slater; R Forman; E S Monrad; J D Talley; J S Hochman
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

4.  Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function.

Authors:  Robert C Scott; Jenna M Rosano; Zhanna Ivanov; Bin Wang; Parkson Lee-Gau Chong; Andrew C Issekutz; Deborah L Crabbe; Mohammad F Kiani
Journal:  FASEB J       Date:  2009-06-17       Impact factor: 5.191

5.  A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.

Authors:  Ho Lun Wong; Reina Bendayan; Andrew M Rauth; Hui Yi Xue; Karlo Babakhanian; Xiao Yu Wu
Journal:  J Pharmacol Exp Ther       Date:  2006-03-17       Impact factor: 4.030

6.  Ventricular septal rupture complicating acute myocardial infarction: identification of simple and complex types in 53 autopsied hearts.

Authors:  B S Edwards; W D Edwards; J E Edwards
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

7.  Delivery of microRNA-1 inhibitor by dendrimer-based nanovector: An early targeting therapy for myocardial infarction in mice.

Authors:  Xiaomei Xue; Xueyin Shi; Haiqing Dong; Shasha You; Huimin Cao; Kun Wang; Ya Wen; Donglu Shi; Bin He; Yongyong Li
Journal:  Nanomedicine       Date:  2017-12-18       Impact factor: 5.307

8.  Time course of coronary endothelial healing after injury due to ischemia and reperfusion.

Authors:  L D Horwitz; D Kaufman; M W Keller; Y Kong
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

9.  MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs.

Authors:  Khatia Gabisonia; Giulia Prosdocimo; Giovanni Donato Aquaro; Lucia Carlucci; Lorena Zentilin; Ilaria Secco; Hashim Ali; Luca Braga; Nikoloz Gorgodze; Fabio Bernini; Silvia Burchielli; Chiara Collesi; Lorenzo Zandonà; Gianfranco Sinagra; Marcello Piacenti; Serena Zacchigna; Rossana Bussani; Fabio A Recchia; Mauro Giacca
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

10.  Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction.

Authors:  J Šímová; J Škvor; D Slovák; I Mazura; J Zvárová
Journal:  Folia Biol (Praha)       Date:  2013       Impact factor: 0.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.